• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微迷你环基因治疗:大小对发酵、复合物形成、抗剪切和表达的影响。

Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression.

机构信息

Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Stockholm, Sweden.

YKI, Institute for Surface Chemistry, Stockholm, Sweden.

出版信息

Mol Ther Nucleic Acids. 2014 Jan 7;2(1):e140. doi: 10.1038/mtna.2013.67.

DOI:10.1038/mtna.2013.67
PMID:24399204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3910003/
Abstract

The minicircle (MC), composed of eukaryotic sequences only, is an interesting approach to increase the safety and efficiency of plasmid-based vectors for gene therapy. In this paper, we investigate micro-MC (miMC) vectors encoding small regulatory RNA. We use a construct encoding a splice-correcting U7 small nuclear RNA, which results in a vector of 650 base pairs (bp), as compared to a conventional 3600 bp plasmid carrying the same expression cassette. Furthermore, we construct miMCs of varying sizes carrying different number of these cassettes. This allows us to evaluate how size influences production, super-coiling, stability and efficiency of the vector. We characterize coiling morphology by atomic force microscopy and measure the resistance to shearing forces caused by an injector device, the Biojector. We compare the behavior of miMCs and plasmids in vitro using lipofection and electroporation, as well as in vivo in mice. We here show that when the size of the miMC is reduced, the formation of dimers and trimers increases. There seems to be a lower size limit for efficient expression. We demonstrate that miMCs are more robust than plasmids when exposed to shearing forces, and that they show extended expression in vivo.Molecular Therapy-Nucleic Acids (2014); doi:10.1038/mtna.2013.67.

摘要

微环(MC)仅由真核序列组成,是提高基于质粒的基因治疗载体安全性和效率的一种有趣方法。在本文中,我们研究了编码小调控 RNA 的微环(miMC)载体。我们使用了一种编码剪接校正 U7 小核 RNA 的构建体,其结果是产生了 650 个碱基对(bp)的载体,而不是携带相同表达盒的传统 3600bp 质粒。此外,我们构建了不同大小的 miMC,携带不同数量的这些盒。这使我们能够评估大小如何影响载体的生产、超螺旋、稳定性和效率。我们通过原子力显微镜描绘了卷曲形态,并测量了由注射器装置(Biojector)引起的剪切力的阻力。我们通过脂质转染和电穿孔在体外以及在小鼠体内比较了 miMC 和质粒的行为。我们在此表明,当 miMC 的大小减小时,二聚体和三聚体的形成增加。似乎存在一个有效表达的最小尺寸限制。我们证明,与质粒相比,miMC 在受到剪切力时更具韧性,并且在体内表现出延长的表达。《分子治疗-核酸》(2014 年);doi:10.1038/mtna.2013.67。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/54690362eb18/mtna201367f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/a0b89c7b40b9/mtna201367f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/a610fbe9dc10/mtna201367f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/0e83ca08cf01/mtna201367f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/16a25a7c9303/mtna201367f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/385adfc9eb54/mtna201367f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/c7a936010ff8/mtna201367f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/fd110ae01256/mtna201367f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/54690362eb18/mtna201367f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/a0b89c7b40b9/mtna201367f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/a610fbe9dc10/mtna201367f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/0e83ca08cf01/mtna201367f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/16a25a7c9303/mtna201367f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/385adfc9eb54/mtna201367f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/c7a936010ff8/mtna201367f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/fd110ae01256/mtna201367f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a070/3910003/54690362eb18/mtna201367f8.jpg

相似文献

1
Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression.微迷你环基因治疗:大小对发酵、复合物形成、抗剪切和表达的影响。
Mol Ther Nucleic Acids. 2014 Jan 7;2(1):e140. doi: 10.1038/mtna.2013.67.
2
Safety and efficacy of DNA vaccines: plasmids vs. minicircles.DNA疫苗的安全性与有效性:质粒与微型环
Hum Vaccin Immunother. 2014;10(5):1306-8. doi: 10.4161/hv.28077. Epub 2014 Feb 19.
3
Performance of high quality minicircle DNA for in vitro and in vivo gene transfer.高质量迷你-circle DNA 用于体外和体内基因转移的性能。
Mol Biotechnol. 2013 Jan;53(1):80-9. doi: 10.1007/s12033-012-9535-6.
4
Gene transfer to mouse heart and skeletal muscles using a minicircle expressing human vascular endothelial growth factor.利用表达人血管内皮生长因子的微环向小鼠心脏和骨骼肌进行基因转移。
J Cardiovasc Pharmacol. 2009 Jan;53(1):18-23. doi: 10.1097/FJC.0b013e318194234e.
5
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.改进了不含质粒细菌序列且能够在体内持续进行转基因表达的微型环状DNA载体的生产和纯化。
Hum Gene Ther. 2005 Jan;16(1):126-31. doi: 10.1089/hum.2005.16.126.
6
Use of minicircle plasmids for gene therapy.微小环质粒在基因治疗中的应用。
Methods Mol Biol. 2009;542:87-104. doi: 10.1007/978-1-59745-561-9_4.
7
Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.紧扭的微小环载体用于基因治疗:优于超螺旋微小环 DNA 的潜在改进。
Med Hypotheses. 2010 Apr;74(4):702-4. doi: 10.1016/j.mehy.2009.10.035. Epub 2009 Nov 13.
8
An in vitro approach for production of non-scar minicircle DNA vectors.体外生产非疤痕微环 DNA 载体的方法。
J Biotechnol. 2013 Jul 10;166(3):84-7. doi: 10.1016/j.jbiotec.2013.04.008. Epub 2013 May 2.
9
Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields.最小抗生素游离质粒细胞载体的关键设计标准,对于结合稳健的 RNA Pol II 和 Pol III 介导的真核表达与高细菌生产产量是必要的。
J Gene Med. 2010 Oct;12(10):818-31. doi: 10.1002/jgm.1499.
10
Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene.携带人锰超氧化物歧化酶转基因的微小环质粒在体内外的辐射防护作用
Hum Gene Ther. 2008 Aug;19(8):820-6. doi: 10.1089/hum.2007.141.

引用本文的文献

1
Anticodon Edited Transfer RNAs (ACE-tRNAs) Encoded as Therapeutic Nonviral Minimal DNA Vectors.编码为治疗性非病毒最小DNA载体的反密码子编辑转运RNA(ACE-tRNA)
bioRxiv. 2025 Sep 6:2025.09.06.674645. doi: 10.1101/2025.09.06.674645.
2
Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials.无抗生素基因载体:25 年走向临床试验。
Genes (Basel). 2024 Feb 20;15(3):261. doi: 10.3390/genes15030261.
3
Cluster Formation in Solutions of Polyelectrolyte Rings.聚电解质环溶液中的聚集体形成

本文引用的文献

1
Extreme bendability of DNA less than 100 base pairs long revealed by single-molecule cyclization.单分子环化实验揭示了长度小于 100 个碱基对的 DNA 的极端柔韧性。
Science. 2012 Aug 31;337(6098):1097-101. doi: 10.1126/science.1224139.
2
[A minicircle DNA vector-mediated siRNA to stably suppress hepatitis B virus replication and expression].一种微小环状DNA载体介导的小干扰RNA稳定抑制乙型肝炎病毒复制和表达
Wei Sheng Wu Xue Bao. 2012 Feb 4;52(2):191-7.
3
Role of non-specific DNA in reducing coding DNA requirement for transient gene expression with CHO and HEK-293E cells.
ACS Nano. 2023 Nov 14;17(21):21369-21382. doi: 10.1021/acsnano.3c06083. Epub 2023 Sep 20.
4
Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD.表达新冠病毒受体结合域的微小环状DNA疫苗产量最大化
Biomedicines. 2022 Apr 25;10(5):990. doi: 10.3390/biomedicines10050990.
5
A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics.一种用于前列腺癌诊疗的、由生存素驱动的肿瘤可激活微型环系统。
Mol Ther Oncolytics. 2021 Jan 20;20:209-219. doi: 10.1016/j.omto.2021.01.007. eCollection 2021 Mar 26.
6
A Novel Cre Recombinase-Mediated Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus.新型 Cre 重组酶介导的微环 DNA (CRIM) 疫苗为对抗新城疫病毒提供部分保护。
Appl Environ Microbiol. 2019 Jul 1;85(14). doi: 10.1128/AEM.00407-19. Print 2019 Jul 15.
7
Efficient episomal gene transfer to human hepatic cells using the pFAR4-S/MAR vector.利用 pFAR4-S/MAR 载体高效转染人肝细胞中的外源性基因。
Mol Biol Rep. 2019 Jun;46(3):3203-3211. doi: 10.1007/s11033-019-04777-9. Epub 2019 Apr 12.
8
Nonviral Gene Therapy for Cancer: A Review.癌症的非病毒基因治疗:综述
Diseases. 2018 Jul 3;6(3):57. doi: 10.3390/diseases6030057.
9
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.用 HIV-1 包膜 T20 编码 DNA 疫苗进行免疫接种可引起跨谱系中和抗体反应。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2849-2858. doi: 10.1080/21645515.2017.1338546. Epub 2017 Jul 11.
10
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.DNA 疫苗载体、非机械传递方法以及提高免疫原性的分子佐剂的进展。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2837-2848. doi: 10.1080/21645515.2017.1330236. Epub 2017 Jun 12.
非特异性 DNA 在降低 CHO 和 HEK-293E 细胞瞬时基因表达中对编码 DNA 需求的作用。
Biotechnol Bioeng. 2012 Sep;109(9):2271-8. doi: 10.1002/bit.24494. Epub 2012 Mar 30.
4
New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.新一代无抗生素抗性标记质粒骨架,用于基因治疗试验。
Mol Ther. 2011 Nov;19(11):1942-9. doi: 10.1038/mt.2011.182. Epub 2011 Aug 30.
5
Supercoiled Minivector DNA resists shear forces associated with gene therapy delivery.超螺旋微小载体 DNA 可抵抗与基因治疗输送相关的剪切力。
Gene Ther. 2012 Jan;19(1):94-100. doi: 10.1038/gt.2011.77. Epub 2011 Jun 2.
6
A robust system for production of minicircle DNA vectors.一种用于生产微环 DNA 载体的稳健系统。
Nat Biotechnol. 2010 Dec;28(12):1287-9. doi: 10.1038/nbt.1708. Epub 2010 Nov 21.
7
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells.转染几百个碱基对的短发夹 RNA 编码的小载体 DNA 以调节淋巴瘤细胞中的基因表达。
Gene Ther. 2011 Mar;18(3):220-4. doi: 10.1038/gt.2010.123. Epub 2010 Oct 21.
8
Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.转基因丢失和启动子甲基化状态的变化作为影响因子IX非病毒基因转移中表达持续时间的决定因素。
Hum Gene Ther. 2011 Jan;22(1):101-6. doi: 10.1089/hum.2009.212. Epub 2010 Dec 6.
9
Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.非病毒纳米载体用于基因传递:影响治疗成功的因素。
Expert Opin Drug Deliv. 2010 Jun;7(6):721-35. doi: 10.1517/17425241003716810.
10
An ancient mechanism for splicing control: U11 snRNP as an activator of alternative splicing.一种古老的剪接调控机制:U11 snRNP 作为可变剪接的激活因子。
Mol Cell. 2010 Mar 26;37(6):821-33. doi: 10.1016/j.molcel.2010.02.014.